Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
VALID Act of 2023
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to clinical trials at the National Cancer Institute H.R.2369,VALID Act of 2023
PREVENT HPV Cancers Act of 2023
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2024 · third_quarter · Q3
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to clinical trials at the National Cancer Institute U.S. Preventive Services Task Force (USPSTF) Guidelines H.R.3633, PREVENT HPV Cancers Act of 2023
Issues related to medical device supply chain
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Source: Senate LDA
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to clinical trials at the National Cancer Institute U.S. Preventive Services Task Force (USPSTF) Guidelines H.R.3633, PREVENT HPV Cancers Act of 2023
VALID Act of 2023
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency H.R.2369, VALID Act of 2023
VALID Act of 2023
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency H.R.2369, VALID Act of 2023
VALID Act of 2023
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to influenza H.R.2369, VALID Act of 2023
VALID Act of 2023
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency H.R.2369, VALID Act of 2023
Triple A Study Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2290, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act H.R.2631, Amputation Reduction and Compassion Act Issues related to chronic disease
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2290, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act H.R.2631, Amputation Reduction and Compassion Act Issues related to chronic disease
VALID Act of 2021
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2209, VALID Act of 2021 Issues related to Hernia awareness Issues related to Oncology
VALID Act of 2021
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency H.R.4128, VALID Act of 2021 S.2209, VALID Act of 2021
VALID Act of 2021
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2290, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act H.R.2631, Amputation Reduction and Compassion Act Issues related to chronic disease
VALID Act of 2021
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2209, VALID Act of 2021 Issues related to Hernia awareness Issues related to Oncology
To amend the Families First Coronavirus Response Act to extend child nutrition waiver authority, and for other purposes.
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2290, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act H.R.2631, Amputation Reduction and Compassion Act Issues related to chronic disease
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2209, VALID Act of 2021 Issues related to Hernia awareness Issues related to Oncology
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency H.R.4128, VALID Act of 2021 S.2209, VALID Act of 2021
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2209, VALID Act of 2021 Issues related to Hernia awareness Issues related to Oncology
Data Broker List Act of 2021
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2290, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act H.R.2631, Amputation Reduction and Compassion Act Issues related to chronic disease
Triple A Study Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to diagnostic testing Issues related to legal reform Issues related to data privacy H.R.2631, ARC Act of 2021 H.R.4128, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act S.4760, PASTEUR Act
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to diagnostic testing Issues related to legal reform Issues related to data privacy H.R.2631, ARC Act of 2021 H.R.4128, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act S.4760, PASTEUR Act
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to antimicrobial stewardship Issues related to diagnostic testing H.R.2631, ARC Act of 2021 H.R.4128, VALID Act of 2021
VALID Act of 2021
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.4760, PASTEUR Act
VALID Act of 2021
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to diagnostic testing Issues related to legal reform Issues related to data privacy H.R.2631, ARC Act of 2021 H.R.4128, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act S.4760, PASTEUR Act
VALID Act of 2021
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to antimicrobial stewardship Issues related to diagnostic testing H.R.2631, ARC Act of 2021 H.R.4128, VALID Act of 2021
To amend the Families First Coronavirus Response Act to extend child nutrition waiver authority, and for other purposes.
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to diagnostic testing Issues related to legal reform Issues related to data privacy H.R.2631, ARC Act of 2021 H.R.4128, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act S.4760, PASTEUR Act
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to diagnostic testing Issues related to legal reform Issues related to data privacy H.R.2631, ARC Act of 2021 H.R.4128, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act S.4760, PASTEUR Act
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.4760, PASTEUR Act
To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes.
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.748, CARES Act H.R.2064, Sunshine for Samples Act of 2019 H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 S.3404, VALID Act of 2020 Issues related to medication safety Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response
DISARM Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 H.R.6102, VALID Act of 2020 Issues related to medication safety Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act
DISARM Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.748, CARES Act H.R.2064, Sunshine for Samples Act of 2019 H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 S.3404, VALID Act of 2020 Issues related to medication safety Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response
DISARM Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act Issues related to medical device supply chains Issues related to community health centers Issues related to health legal reform
DISARM Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 H.R.6102, VALID Act of 2020 Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act Issues related to medical device supply chains
VALID Act of 2020
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 H.R.6102, VALID Act of 2020 Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act Issues related to medical device supply chains
VALID Act of 2020
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 H.R.6102, VALID Act of 2020 Issues related to medication safety Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act
H.R.748, CARES Act H.R.2064, Sunshine for Samples Act of 2019 H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 S.3404, VALID Act of 2020 Issues related to medication safety Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response
H.R.748, CARES Act H.R.2064, Sunshine for Samples Act of 2019 H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 S.3404, VALID Act of 2020 Issues related to medication safety Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response
U.S. MADE Act of 2020
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to trade and tariffs China export policy S.4264, U.S. MADE Act of 2020
U.S. MADE Act of 2020
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to trade and tariffs China export policy S.4264, U.S. MADE Act of 2020
To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes.
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2064, Sunshine for Samples Act of 2019 H.R.3129, Jeanette Acosta Invest in Women's Health Act of 2019 Issues related to hazardous drug safety Issues related to medication safety and drug diversion Issues related to device cyber security Issues related to medical device sterilization Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to end-stage renal disease devices Issues related to data privacy
To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes.
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2064, Sunshine for Samples Act of 2019 H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 Issues related to medication safety Issues related to medical device sterilization Issues related to medical technology regulation Issues related to end-stage renal disease devices Issues related to data privacy
To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes.
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2064, Sunshine for Samples Act of 2019 H.R.3129, Jeanette Acosta Invest in Women's Health Act of 2019 Issues related to medication safety Issues related to device cyber security Issues related to medical device sterilization Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to end-stage renal disease devices Issues related to data privacy
Protect Medical Innovation Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2207, Protect Medical Innovation Act of 2019, repeal of the medical device tax S.692, Protect Medical Innovation Act of 2019, repeal of the medical device tax
Protect Medical Innovation Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2207, Protect Medical Innovation Act of 2019, repeal of the medical device tax S.692, Protect Medical Innovation Act of 2019, repeal of the medical device tax
Protect Medical Innovation Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2207, Protect Medical Innovation Act of 2019, repeal of the medical device tax S.692, Protect Medical Innovation Act of 2019, repeal of the medical device tax
Protect Medical Innovation Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2207, Protect Medical Innovation Act of 2019, repeal of the medical device tax S.692, Protect Medical Innovation Act of 2019, repeal of the medical device tax
Jeanette Acosta Invest in Women’s Health Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2064, Sunshine for Samples Act of 2019 H.R.3129, Jeanette Acosta Invest in Women's Health Act of 2019 Issues related to hazardous drug safety Issues related to medication safety and drug diversion Issues related to device cyber security Issues related to medical device sterilization Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to end-stage renal disease devices Issues related to data privacy
Jeanette Acosta Invest in Women’s Health Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2064, Sunshine for Samples Act of 2019 H.R.3129, Jeanette Acosta Invest in Women's Health Act of 2019 Issues related to medication safety Issues related to device cyber security Issues related to medical device sterilization Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to end-stage renal disease devices Issues related to data privacy
DISARM Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2064, Sunshine for Samples Act of 2019 H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 Issues related to medication safety Issues related to medical device sterilization Issues related to medical technology regulation Issues related to end-stage renal disease devices Issues related to data privacy
Protect Medical Innovation Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2207, Protect Medical Innovation Act of 2019, repeal of the medical device tax S.692, Protect Medical Innovation Act of 2019, repeal of the medical device tax
Protect Medical Innovation Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2207, Protect Medical Innovation Act of 2019, repeal of the medical device tax S.692, Protect Medical Innovation Act of 2019, repeal of the medical device tax
Protect Medical Innovation Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2207, Protect Medical Innovation Act of 2019, repeal of the medical device tax S.692, Protect Medical Innovation Act of 2019, repeal of the medical device tax
Protect Medical Innovation Act of 2019
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.2207, Protect Medical Innovation Act of 2019, repeal of the medical device tax S.692, Protect Medical Innovation Act of 2019, repeal of the medical device tax
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2017 H.R.1, Tax Cuts and Jobs Act
Protect Medical Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2017 H.R.1, Tax Cuts and Jobs Act
Protect Medical Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2017 S.108, Medical Device Access and Innovation Protection Act
Protect Medical Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2018 S.108, Medical Device Access and Innovation Protection Act
Protect Medical Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2017 S.108, Medical Device Access and Innovation Protection Act
FDA Reauthorization Act of 2017
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.2430, FDA Reauthorization Act of 2017 VA procurement Issues related to hazardous drug safety Issues related to medical technology regulation P.L.109-417 PAHPA Opioids
Veterans Affairs Medical-Surgical Purchasing Stabilization Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combating Opioid Abuse for Care in Hospitals Act of 2018
Veterans Affairs Medical-Surgical Purchasing Stabilization Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act S.2248, Veterans Benefits and Transition Act of 2018 Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018 Issues related to device cybersecurity
Veterans Affairs Medical-Surgical Purchasing Stabilization Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018
COACH Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018
COACH Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combating Opioid Abuse for Care in Hospitals Act of 2018
COACH Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act S.2248, Veterans Benefits and Transition Act of 2018 Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018 Issues related to device cybersecurity
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2018 S.108, Medical Device Access and Innovation Protection Act
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2017 S.108, Medical Device Access and Innovation Protection Act
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2017 S.108, Medical Device Access and Innovation Protection Act
Veterans Benefits and Transition Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act S.2248, Veterans Benefits and Transition Act of 2018 Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018 Issues related to device cybersecurity
Opioid Crisis Response Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018
Opioid Crisis Response Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act S.2248, Veterans Benefits and Transition Act of 2018 Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018 Issues related to device cybersecurity
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act S.2248, Veterans Benefits and Transition Act of 2018 Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018 Issues related to device cybersecurity
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combating Opioid Abuse for Care in Hospitals Act of 2018
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2017 H.R.1, Tax Cuts and Jobs Act, Issues related to corporate tax
Protect Medical Innovation Act of 2018
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.184, Protect Medical Innovation Act of 2017 H.R.1, Tax Cuts and Jobs Act, Issues related to corporate tax
FDA Reauthorization Act of 2017
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to antimicrobial resistance Clinical lab fee schedule H.R.2430, FDA Reauthorization Act of 2017 VA procurement Issues related to hazardous drug safety Issues related to medical technology regulation
Protect Medical Innovation Act of 2015
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.160, Protect Medical Innovation Act of 2015, Issues related to medical device tax Issues related to corporate tax
Protect Medical Innovation Act of 2015
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.160, Protect Medical Innovation Act of 2015, Issues related to medical device tax Issues related to corporate tax
21st Century Cures Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to diagnostic regulation Issues related to device regulation H.R. 34, 21st Century Cures Act Issues related to hazardous drug safety Issues related to opioid safety
21st Century Cures Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to diagnostic regulation Issues related to device regulation H.R. 34, 21st Century Cures Act Issues related to hazardous drug safety Issues related to opioid safety
Protect Medical Innovation Act of 2015
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act H.R.160, Protect Medical Innovation Act of 2015
Protect Medical Innovation Act of 2015
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act, issues related to medical device tax H.R.160, Protect Medical Innovation Act of 2015, issues related to medical device tax
Protect Medical Innovation Act of 2015
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.160, Protect Medical Innovation Act of 2015 S.149, Medical Device Access and Innovation Protection Act Issues related to international tax
Protect Medical Innovation Act of 2015
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act H.R.160, Protect Medical Innovation Act of 2015
Protect Medical Innovation Act of 2015
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act H.R.160, Protect Medical Innovation Act of 2015
Protect Medical Innovation Act of 2015
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act, issues related to medical device tax H.R.160, Protect Medical Innovation Act of 2015, issues related to medical device tax
Consolidated Appropriations Act, 2016
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R. 2029, Consolidated Appropriations Act, 2016, NIH Funding
Strengthening Public Health Emergency Response Act of 2016
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.3299, Strengthening Public Health Emergency Response Act of 2015 S.2153, Provider Payment Sunshine Act Issues related to diagnostic regulation Issues related to drug shortages
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act H.R.160, Protect Medical Innovation Act of 2015
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act H.R.160, Protect Medical Innovation Act of 2015
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act H.R.160, Protect Medical Innovation Act of 2015
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act, issues related to medical device tax H.R.160, Protect Medical Innovation Act of 2015, issues related to medical device tax
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act, issues related to medical device tax H.R.160, Protect Medical Innovation Act of 2015, issues related to medical device tax
Medical Device Access and Innovation Protection Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.160, Protect Medical Innovation Act of 2015 S.149, Medical Device Access and Innovation Protection Act Issues related to international tax
Provider Payment Sunshine Act
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.3299, Strengthening Public Health Emergency Response Act of 2015 S.2153, Provider Payment Sunshine Act Issues related to diagnostic regulation Issues related to drug shortages
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
NIH Funding PEPFAR Funding Medicare Budget BARDA Funding H.Con.Res. 25, Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
NIH Funding PEPFAR Funding Medicare Budget BARDA Funding H.Con.Res. 25, Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Antibiotic Development to Advance Patient Treatment Act of 2013
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to safe handling of hazardous drugs Issues related to pandemic preparedness H.R. 3742, Antibiotic Development to Advance Patient Treatment Act of 2013 Issues related to device regulation
Antibiotic Development to Advance Patient Treatment Act of 2013
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.3742, Antibiotic Development to Advance Patient Treatment Act of 2013 Issues related to medication errors Issues related to pandemic preparedness Issues related to device regulation Issues related to diagnostic regulation Issues related to biomedical research
Antibiotic Development to Advance Patient Treatment Act of 2013
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
Issues related to safe handling of hazardous drugs Issues related to pandemic preparedness H.R. 3742, Antibiotic Development to Advance Patient Treatment Act of 2013 Issues related to device regulation
Antibiotic Development to Advance Patient Treatment Act of 2013
Client: BECTON DICKINSON AND COMPANY · Firm: BECTON, DICKINSON AND COMPANY
H.R.3742, Antibiotic Development to Advance Patient Treatment Act of 2013 Issues related to medication errors Issues related to pandemic preparedness Issues related to device regulation Issues related to diagnostic regulation Issues related to biomedical research
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2024 · second_quarter · Q2
Issues related to medical device supply chain
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2024 · first_quarter · Q1
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to clinical trials at the National Cancer Institute H.R.2369,VALID Act of 2023
Issues related to medical device supply chain
Issues related to corporate taxation Tax incentives for domestic manufacturing
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2023 · fourth_quarter · Q4
Issues related to medical device supply chain
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency H.R.2369, VALID Act of 2023
Issues related to corporate taxation Tax incentives for domestic manufacturing
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2023 · third_quarter · Q3
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency H.R.2369, VALID Act of 2023
Issues related to corporate taxation Tax incentives for domestic manufacturing
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2023 · second_quarter · Q2
Issues related to corporate taxation Tax incentives for domestic manufacturing
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency H.R.2369, VALID Act of 2023
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2023 · first_quarter · Q1
Issues related to corporate taxation Tax incentives for domestic manufacturing
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to influenza H.R.2369, VALID Act of 2023
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2022 · fourth_quarter · Q4
Issues related to corporate taxation Tax incentives for domestic manufacturing
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency H.R.4128, VALID Act of 2021 S.2209, VALID Act of 2021
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2022 · third_quarter · Q3
Issues related to corporate taxation Tax incentives for domestic manufacturing
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2209, VALID Act of 2021 Issues related to Hernia awareness Issues related to Oncology
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2022 · second_quarter · Q2
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2209, VALID Act of 2021 Issues related to Hernia awareness Issues related to Oncology
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2022 · first_quarter · Q1
Issues related to corporate taxation Tax incentives for domestic manufacturing
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.2290, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act H.R.2631, Amputation Reduction and Compassion Act Issues related to chronic disease
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2021 · fourth_quarter · Q4
Issues related to medical device sterilization Issues related to medical technology regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers H.R.4128, VALID Act of 2021 S.4760, PASTEUR Act
Issues related to corporate taxation
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2021 · third_quarter · Q3
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to pandemic preparedness and coronavirus response Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to diagnostic testing Issues related to legal reform Issues related to data privacy H.R.2631, ARC Act of 2021 H.R.4128, VALID Act of 2021 H.R.2461, Triple A Study Act S.1089, Triple A Study Act S.4760, PASTEUR Act
Issues related to trade and tariffs Issues related to US centric procurement policy
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2021 · second_quarter · Q2
Issues related to trade and tariffs Issues related to US centric procurement policy
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to antimicrobial stewardship Issues related to diagnostic testing H.R.2631, ARC Act of 2021 H.R.4128, VALID Act of 2021
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2021 · first_quarter · Q1
Issues related to trade and tariffs China export policy Issues related to US centric procurement policy
Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act Issues related to medical device supply chains and supply chain resiliency Issues related to community health centers Issues related to antimicrobial stewardship Issues related to Peripheral artery disease
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2020 · fourth_quarter · Q4
Issues related to trade and tariffs China export policy S.4264, U.S. MADE Act of 2020
H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act Issues related to medical device supply chains Issues related to community health centers Issues related to health legal reform
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2020 · third_quarter · Q3
Issues related to trade and tariffs China export policy S.4264, U.S. MADE Act of 2020
H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 H.R.6102, VALID Act of 2020 Issues related to medication safety and drug diversion Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act Issues related to medical device supply chains
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2020 · second_quarter · Q2
H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 H.R.6102, VALID Act of 2020 Issues related to medication safety Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response Issues related to Defense Production Act
Issues related to trade and tariffs
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2020 · first_quarter · Q1
H.R.748, CARES Act H.R.2064, Sunshine for Samples Act of 2019 H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 S.3404, VALID Act of 2020 Issues related to medication safety Issues related to medical device sterilization Issues related to medical technology/device regulation Issues related to end-stage renal disease Issues related to data privacy Issues related to pandemic preparedness and coronavirus response
Issues related to trade and tariffs
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2019 · fourth_quarter · Q4
H.R.2064, Sunshine for Samples Act of 2019 H.R.4100, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 Issues related to medication safety Issues related to medical device sterilization Issues related to medical technology regulation Issues related to end-stage renal disease devices Issues related to data privacy
China tariffs Steel aluminum tariffs
H.R.2207, Protect Medical Innovation Act of 2019, repeal of the medical device tax S.692, Protect Medical Innovation Act of 2019, repeal of the medical device tax
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2019 · third_quarter · Q3
China tariffs Steel aluminum tariffs
H.R.2064, Sunshine for Samples Act of 2019 H.R.3129, Jeanette Acosta Invest in Women's Health Act of 2019 Issues related to medication safety Issues related to device cyber security Issues related to medical device sterilization Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to end-stage renal disease devices Issues related to data privacy
H.R.2207, Protect Medical Innovation Act of 2019, repeal of the medical device tax S.692, Protect Medical Innovation Act of 2019, repeal of the medical device tax
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2019 · second_quarter · Q2
China tariffs Steel aluminum tariffs
H.R.2064, Sunshine for Samples Act of 2019 H.R.3129, Jeanette Acosta Invest in Women's Health Act of 2019 Issues related to hazardous drug safety Issues related to medication safety and drug diversion Issues related to device cyber security Issues related to medical device sterilization Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to end-stage renal disease devices Issues related to data privacy
H.R.2207, Protect Medical Innovation Act of 2019, repeal of the medical device tax S.692, Protect Medical Innovation Act of 2019, repeal of the medical device tax
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2019 · first_quarter · Q1
H.R.2207, Protect Medical Innovation Act of 2019, repeal of the medical device tax S.692, Protect Medical Innovation Act of 2019, repeal of the medical device tax
Issues related to medication safety and drug diversion Issues related to device cyber security Issues related to Veterans Affairs procurement of medical devices Issues related to medical device sterilization Issues related to hazardous drug safety Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to end-stage renal disease devices
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2018 · fourth_quarter · Q4
China tariffs
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act S.2248, Veterans Benefits and Transition Act of 2018 Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018 Issues related to device cybersecurity
H.R.184, Protect Medical Innovation Act of 2018 S.108, Medical Device Access and Innovation Protection Act
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2018 · third_quarter · Q3
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combatting Opioid Abuse for Care in Hospitals (COACH) Act of 2018 S.2680, The Opioid Response Act of 2018
China tariffs
H.R.184, Protect Medical Innovation Act of 2017 S.108, Medical Device Access and Innovation Protection Act
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2018 · second_quarter · Q2
Issues related to antimicrobial resistance H.R.5418, Veterans Affairs Medical-Surgical Purchasing Stabilization Act Issues related to hazardous drug safety Issues related to medical technology regulation S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.5774, Combating Opioid Abuse for Care in Hospitals Act of 2018
H.R.184, Protect Medical Innovation Act of 2017 S.108, Medical Device Access and Innovation Protection Act
Administration tariffs
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2018 · first_quarter · Q1
Issues related to antimicrobial resistance H.R.2430, FDA Reauthorization Act of 2017 VA procurement Issues related to hazardous drug safety Issues related to medical technology regulation P.L.109-417 PAHPA Opioids
H.R.184, Protect Medical Innovation Act of 2017 H.R.1, Tax Cuts and Jobs Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2017 · fourth_quarter · Q4
H.R.184, Protect Medical Innovation Act of 2017 H.R.1, Tax Cuts and Jobs Act, Issues related to corporate tax
Issues related to antimicrobial resistance Clinical lab fee schedule H.R.2430, FDA Reauthorization Act of 2017 VA procurement Issues related to hazardous drug safety Issues related to medical technology regulation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2016 · fourth_quarter · 4A
Issues related to diagnostic regulation Issues related to device regulation H.R. 34, 21st Century Cures Act Issues related to hazardous drug safety Issues related to opioid safety
Issues related to value-based purchasing Issues related to UDI on Medicare claim forms Issues related to Flow cytometry reimbursement Issues related to Conditions of Participation
H.R.160, Protect Medical Innovation Act of 2015, Issues related to medical device tax Issues related to corporate tax
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2016 · second_quarter · 2A
Issues related to medical device tax Issues related to corporate tax
Issues related to diagnostic regulation Issues related to drug shortages Issues related to veteran's health care WHO Prequalification program Issues related to device regulation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2016 · fourth_quarter · Q4
H.R.160, Protect Medical Innovation Act of 2015, Issues related to medical device tax Issues related to corporate tax
Issues related to value-based purchasing Issues related to UDI on Medicare claim forms Issues related to Flow cytometry reimbursement Issues related to Conditions of Participation
Issues related to diagnostic regulation Issues related to device regulation H.R. 34, 21st Century Cures Act Issues related to hazardous drug safety Issues related to opioid safety
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2016 · second_quarter · Q2
Issues related to medical device tax Issues related to corporate tax
Issues related to diagnostic regulation Issues related to drug shortages Issues related to veteran's health care WHO Prequalification program Issues related to device regulation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2016 · first_quarter · Q1
Issues related to medical device tax repeal Issues related to international tax
Issues related to diagnostic regulation Bio-specimen regulatory issue Issues related to drug shortages Issues related to pandemic preparedness Issues related to Health IT
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2015 · fourth_quarter · Q4
Diagnostics reimbursement Issues related to UDI on medical claim forms
H.R.3299, Strengthening Public Health Emergency Response Act of 2015 S.2153, Provider Payment Sunshine Act Issues related to diagnostic regulation Issues related to drug shortages
H.R.160, Protect Medical Innovation Act of 2015 S.149, Medical Device Access and Innovation Protection Act Issues related to international tax
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2015 · third_quarter · Q3
Issues related to Sharps disposal reimbursement Diagnostics reimbursement Issues related to UDI on medical claim forms
NIH Funding
Issues related to diagnostic regulation Issues related to drug shortages Issues related to pandemic preparedness
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2015 · second_quarter · 2A
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act H.R.160, Protect Medical Innovation Act of 2015
Issues related to medication safety Issues related to device and diagnostic regulation Issues related to safe handling of hazardous drugs Issues related to drug shortages Issues related to pandemic preparedness Issues related to laboratory developed tests (LDTs)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2015 · first_quarter · 1A
NIH Funding BARDA Funding
Issues related to medication safety Issues related to device and diagnostic regulation Issues related to generic drug regulation
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act, issues related to medical device tax H.R.160, Protect Medical Innovation Act of 2015, issues related to medical device tax
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, Treasury, Dept of
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2015 · second_quarter · Q2
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act H.R.160, Protect Medical Innovation Act of 2015
Issues related to medication safety Issues related to device and diagnostic regulation Issues related to safe handling of hazardous drugs Issues related to drug shortages Issues related to pandemic preparedness Issues related to laboratory developed tests (LDTs)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2015 · first_quarter · Q1
Issues related to medication safety Issues related to device and diagnostic regulation Issues related to generic drug regulation
NIH Funding BARDA Funding
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act, issues related to medical device tax H.R.160, Protect Medical Innovation Act of 2015, issues related to medical device tax
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, Treasury, Dept of
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2014 · fourth_quarter · 4A
H.R.3742, Antibiotic Development to Advance Patient Treatment Act of 2013 Issues related to medication errors Issues related to pandemic preparedness Issues related to device regulation Issues related to diagnostic regulation Issues related to biomedical research
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2014 · third_quarter · 3A
Issues related to safe handling of hazardous drugs Issues related to pandemic preparedness H.R. 3742, Antibiotic Development to Advance Patient Treatment Act of 2013 Issues related to device regulation
S.672, Medicare Safe Needle Disposal Coverage Act of 2013
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2014 · second_quarter · 2A
H.R.436, Protect Medical Innovation Act Issues related to corporate tax reform
Issues related to safe handling of hazardous drugs Issues related to FDA regulation of generic drugs Issues related to pandemic preparedness
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2014 · first_quarter · 1A
H.R. 4302, Protecting Access to Medicare Act of 2014 Clinical lab fee schedule reform
H.R. 436, Protect Medical Innovation Act, related to device tax
Issues related to safe handling of hazardous drugs Healthcare policy issues Issues related to FDA regulation of generic drugs Issues related to HIT Healthcare-associated infections (HAIs) Issues related to diagnostic regulation
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2014 · fourth_quarter · Q4
H.R.3742, Antibiotic Development to Advance Patient Treatment Act of 2013 Issues related to medication errors Issues related to pandemic preparedness Issues related to device regulation Issues related to diagnostic regulation Issues related to biomedical research
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2014 · third_quarter · Q3
S.672, Medicare Safe Needle Disposal Coverage Act of 2013
Issues related to safe handling of hazardous drugs Issues related to pandemic preparedness H.R. 3742, Antibiotic Development to Advance Patient Treatment Act of 2013 Issues related to device regulation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2014 · second_quarter · Q2
H.R.436, Protect Medical Innovation Act Issues related to corporate tax reform
Issues related to safe handling of hazardous drugs Issues related to FDA regulation of generic drugs Issues related to pandemic preparedness
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2014 · first_quarter · Q1
H.R. 4302, Protecting Access to Medicare Act of 2014 Clinical lab fee schedule reform
NIH Funding PEPFAR Funding Medicare Budget BARDA Funding H.Con.Res. 25, Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Issues related to safe handling of hazardous drugs Healthcare policy issues Issues related to FDA regulation of generic drugs Issues related to HIT Healthcare-associated infections (HAIs) Issues related to diagnostic regulation
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2013 · fourth_quarter · Q4
NIH Funding
FDA regulation of diagnostic tests Healthcare-associated infections (HAIs) Healthcare policy and medical technology/device issues
H.R. 436, Protect Medical Innovation Act, related to device tax Corporate tax issues
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2013 · third_quarter · Q3
Reimbursement for diagnostic tests
S.959, Pharmaceutical Compounding Quality and Accountability Act, Issues related to drug compounding FDA regulation of diagnostic tests
H.R.523, Protect Medical Innovation Act of 2013 Corporate tax issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2013 · second_quarter · Q2
Diagnostic reimbursement
H.R.523, Protect Medical Innovation Act of 2013 S.232, Medical Device Access and Innovation Protection Act Device tax amendment Corporate tax issues
S.959, Pharmaceutical Compounding Quality and Accountability Act, Issues related to drug compounding FDA regulation of diagnostic tests Healthcare policy and medical technology issues Issues relating to injection safety for patients and healthcare workers
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2013 · first_quarter · Q1
Diagnostic reimbursement
H.R.523, Protect Medical Innovation Act of 2013 S.232, Medical Device Access and Innovation Protection Act Device tax amendment Corporate tax issues
NIH Funding FDA Funding PEPFAR
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2012 · fourth_quarter · Q4
S. 2105, Cybersecurity Act of 2012
H.R.6626, Health Care Innovation and Marketplace Technologies Act of 2012 Sunshine Act
H.R. 6446, To Create Incentive for Innovative Diagnostics by Improving the Process for Determining Medicare Payment Rates for New Tests.
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2012 · third_quarter · Q3
H.R. 3070, Depts. of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012, regarding NIH Funding S. 3295, Depts. of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013, regarding NIH Funding PL 112-025, Budget Control Act of 2011, related to NIH Funding
H.R. 4174, No Tolls in North Carolina Act of 2012, transportation issues
H.R. 436, Protect Medical Innovation Act of 2011 H.R. 6353, Manufacturing American Innovation Act of 2012 Corporate tax issues
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2012 · second_quarter · Q2
S.3187, Food and Drug Administration Safety and Innovation Act, MDUFA and drug shortage H.R.5651, Food and Drug Administration Reform Act of 2012, MDUFA
H.R.436, Protect Medical Innovation Act of 2011 Corporate tax issues
H.R. 3070, Depts. of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012, NIH, CDC, Global Health Funding S. 3295, Depts. of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013, NIH, CDC, Global Health Funding PL 112-025, Budget Control Act of 2011, issues related to NIH funding
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2012 · first_quarter · Q1
H.R.3207, Modernizing Laboratory Test Standards for Patients Act of 2011 Healthcare policy issues Issues related to FDA regulation of medical devices and diagnostics Issues related to FDA regulation of generic drugs
Corporate tax issues Issues related to Medical Device Tax
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2011 · fourth_quarter · Q4
H.R. 3497, Modern Cures Act of 2011
Corporate tax issues Issues related to Medical Device Tax
H.R.3207, Modernizing Laboratory Test Standards for Patients Act of 2011 H.R.2182, Generating Antibiotic Incentives Now Act of 2011, healthcare-associated infections S.1734, Generating Antibiotic Incentives Now Act of 2011, healthcare-associated infections Healthcare policy issues Issues related to FDA regulation of medical devices and diagnostics Issues related to cervical cancer screening Issues related to FDA regulation of generic drugs Issues related to pandemic influenza preparedness
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2011 · third_quarter · Q3
Issues related to FDA regulation of medical devices and diagnostics Healthcare policy issues Issues related to cervical cancer screening Issues related to safe injection practices Issues related to pandemic influenza preparedness
Issues related to reimbursement for diagnostics Issues related to healthcare reform implementation
Corporate tax issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2011 · second_quarter · Q2
Corporate tax issues
Issues related to FDA regulation of medical devices and diagnostics Healthcare policy issues H.R.2182, Generating Antibiotic Incentives Now Act of 2011 Issues related to safe injection practices Issues related to pandemic influenza preparedness Introducing the company based on geographic or health product-based relevance
H.R.1862, Regenerative Medicine Promotion Act of 2011
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2011 · first_quarter · Q1
Corporate tax issues
Issues related to reimbursement for diagnostics Issues related to Medicare value-based purchasing
Issues related to FDA regulation of medical devices and diagnostics Healthcare policy issues Healthcare reform implementation Safe injection practices Introducing the company based on geographic or health product-based relevance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2010 · fourth_quarter · Q4
P.L. 111-148, Patient Protection and Affordable Care Act of 2010, Issues related to healthcare reform implementation Issues related to reimbursement for diagnostics
Issues relating to needlestick safety
Issues related to FDA regulation of medical devices and diagnostics Healthcare policy issues Introducing the company based on geographic or health product-based relevance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2010 · third_quarter · Q3
Safe injection practices
Issues related to diabetes Issues related to FDA regulation of medical devices Issues related to ISO
P.L. 111-148, Patient Protection and Affordable Care Act of 2010, Implementation of Medicare hospital value-based purchasing for HAIs, issues related to healthcare reform implementation
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2010 · second_quarter · Q2
P.L. 111-148, Patient Protection and Affordable Care Act of 2010, Implementation of Medicare hospital value-based purchasing for HAIs
Issues relating to needlestick safety
H.R.759, Food and Drug Administration Globalization Act of 2009, Issues related to import safety S.882, Drug and Device Accountability Act of 2009, Issues related to import safety S.540, Medical Device Safety Act of 2009, Issues related to federal preemption Issues related to pandemic planning Issues related to FDA regulation of medical devices Issues related to pedigree legislation
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2010 · first_quarter · Q1
Issues related to corporate income tax deferral H.R. 3590, The Patient Protection and Affordable Care Act, Issues related to medical device tax H.R.3962, Affordable Health Care for America Act, Issues related to medical device tax H.R. 4872, Health Care Reconciliation Bill, Issues related to medical device tax
H.R. 3590, The Patient Protection and Affordable Care Act, Issues related to Medicare clinical laboratory fee schedule adjustments H.R.3962, Affordable Health Care for America Act, Issues related to Medicare clinical laboratory fee schedule adjustments
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2009 · fourth_quarter · Q4
H.R. 3590, The Patient Protection and Affordable Care Act, Issues related to healthcare reform, medical device tax, prevention of healthcare-associated infections, physician payment disclosure, Medicare clinical laboratory fee schedule adjustments H.R.3962, Affordable Health Care for America Act, Issues related to healthcare reform, medical device tax, prevention of healthcare-associated infections, physician payment disclosure, Medicare clinical laboratory fee schedule adjustments H.R.759, Food and Drug Administration Globalization Act of 2009, Issues related to import safety Issues related to pandemic planning
H.R.3962, Affordable Health Care for America Act, Issues related to healthcare reform, prevention of healthcare-associated infections, physician payment disclosure, Medicare clinical laboratory fee schedule adjustments H.R. 3590, The Patient Protection and Affordable Care Act, Issues related to healthcare reform, prevention of healthcare-associated infections, physician payment disclosure, Medicare clinical laboratory fee schedule adjustments
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2009 · third_quarter · Q3
H.R.3200, America's Affordable Health Choices Act of 2009, Issues related to medical device tax America's Healthy Future Act of 2009, Issues related to medical device tax and clinical laboratory tax
H.R.3293, Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2010, and for other purposes, Issues related to syringe exchange programs and safe injection practices
H.R. 3200, America's Affordable Health Choices Act of 2009, Issues related to healthcare reform and healthcare-associated infections, and diagnostic payment reform America's Healthy Future Act of 2009, Issues related to healthcare reform, healthcare-associated infections, diagnostic payment reform, and Medicare co-pay for lab services
BECTON DICKINSON AND COMPANY via BECTON, DICKINSON AND COMPANY
2009 · second_quarter · Q2
H.R. 759, Food and Drug Administration Globalization Act of 2009, Issues related to import safety S.301, Physician Payments Sunshine Act of 2009, Issues related to medical device company/physician relationship Issues related to FDA regulation of diagnostic tests Issues related to pandemic flu and H1N1 vaccine Issues related to healthcare reform (H.R. 3200) and healthcare-associated infections Issues related to healthcare reform (H.R. 3200) and diagnostic payment reform Issues related to safe injection practices
H.R.2346, Supplemental Appropriations Act, 2009, Issues relating to H1N1 vaccine and pandemic flu S.1054, Supplemental Appropriations Act, 2009, Issues relating to H1N1 vaccine and pandemic flu
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to corporate taxation
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
China tariffs Steel aluminum tariffs
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 2029, Consolidated Appropriations Act, 2016, NIH Funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to Corporate tax reform S.149, Medical Device Access and Innovation Protection Act H.R.160, Protect Medical Innovation Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
NIH Funding PEPFAR Funding Medicare Budget BARDA Funding H.Con.Res. 25, Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R. 436, Protect Medical Innovation Act, related to device tax
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NIH Funding FDA Funding PEPFAR
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Healthcare policy and medical technology issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 436, Protect Medical Innovation Act of 2011 Corporate tax issues
H.R. 3070, Depts. of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012, regarding NIH funding S. 3295, Depts. of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013, regarding NIH funding H.J. Res. 117, Continuing Appropriations Resolution, 2013, regarding FDA funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 3497, MODDERN Cures Act of 2011
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to reimbursement for diagnostics Issues related to healthcare reform implementation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues relating to needlestick safety
H.R.3962, Affordable Health Care for America Act, Issues related to healthcare reform, prevention of healthcare-associated infections, value-based purchasing, Medicare clinical laboratory fee schedule adjustments H.R. 3590, The Patient Protection and Affordable Care Act, Issues related to healthcare reform, prevention of healthcare-associated infections, value-based purchasing, Medicare clinical laboratory fee schedule adjustments
Issues related to safe injection practices funding Issues related to global health funding Issues related to NIH funding Issues related to pandemic funding
H.R. 3590 (P.L. 111-148), Patient Protection and Affordable Care Act, Issues related to healthcare reform, medical device tax, prevention of healthcare-associated infections, value-based purchasing, Medicare clinical laboratory fee schedule adjustments H.R.3962, Affordable Health Care for America Act, Issues related to healthcare reform, medical device tax, prevention of healthcare-associated infections, value-based purchasing, Medicare clinical laboratory fee schedule adjustments H.R.759, Food and Drug Administration Globalization Act of 2009, Issues related to import safety S.882, Drug and Device Accountability Act of 2009, Issues related to import safety Issues related to pandemic planning
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to corporate income tax deferral H.R. 3590, The Patient Protection and Affordable Care Act, Issues related to medical device tax H.R.3962, Affordable Health Care for America Act, Issues related to medical device tax
H.R. 3590, The Patient Protection and Affordable Care Act, Issues related to healthcare reform, prevention of healthcare-associated infections, physician payment disclosure, Medicare clinical laboratory fee schedule adjustments H.R.3962, Affordable Health Care for America Act, Issues related to healthcare reform, prevention of healthcare-associated infections, physician payment disclosure, Medicare clinical laboratory fee schedule adjustments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S. 1649, WMD Prevention and Preparedness Act of 2009, Issues related to pandemic planning Issues related to impact of healthcare industry jobs Issues related to FDA regulation of medical devices Issues related to cancer screening Pandemic planning
Filing targets: HOUSE OF REPRESENTATIVES, SENATE